StratiCell

• Develops predictive, reproducible in vitro skin equivalents and related assays to be used to accurately predict human skin responses in screening of efficacy and safety endpoints for Health and Beauty Care business.   
• To become a key player in :

• Molecular Toxicology : in vitro contract testing services based on dermal fibroblasts, keratinocytes and 3D skin culture models for cosmetic ingredients and finished products (toxicity, irritation, sensitization, photoprotection, phototoxicity, anti-aging…) 
• Tissue culture : biologically standardized human reconstituted epidermis and skin equivalents for in vitro testing applications (transgenic or wild-type cultures). Critical technological advantages over competitors, further possibilities of technological development 
  
• Contract research organization : Toxicoproteomics, functional biology and low to medium throughput screening

• Opportunistic applications with keratinocyte cultures (burn treatment for instance)